SCHEMBL4583375

SCHEMBL4583375

Nc1cc(C23CC4CC(F)(C2)CC(c2ccc(O)c(N)c2)(C4)C3)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
GFER P55789 1/20 0.44
ALDH1A1 P00352 8/20 0.34
LMNA P02545 3/20 0.33
ALOX15 P16050 3/20 0.33
HSD17B10 Q99714 3/20 0.33
ALOX12 P18054 3/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PGR P06401 1/20 0.32
MAPT P10636 3/20 0.30
HTT P42858 2/20 0.30
KDM4E B2RXH2 1/20 0.30
USP2 O75604 1/20 0.30
HSP90AA1 P07900 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4582985 0.83 ALDH1A1 (0.37) GAAMEN1KMT2APOLBGFER
SCHEMBL4583150 0.82 GAA (0.44) GAAMEN1KMT2APOLBGFER
SCHEMBL4583386 0.82 MEN1 (0.41) GAAMEN1KMT2APOLBGFER
SCHEMBL31544676 0.81 MEN1 (0.57) GAAMEN1KMT2APOLBGFER
SCHEMBL2708128 0.81 MEN1 (0.57) GAAMEN1KMT2APOLBGFER
SCHEMBL1150069 0.78 MEN1 (0.71) GAAMEN1KMT2APOLBGFER
SCHEMBL2710154 0.78 MEN1 (0.71) GAAMEN1KMT2APOLBGFER
SCHEMBL3756585 0.76 MEN1 (0.72) GAAMEN1KMT2APOLBGFER
SCHEMBL5000706 0.75 MEN1 (0.53) GAAMEN1KMT2APOLBGFER
SCHEMBL4583254 0.73 ALDH1A1 (0.34) GAAMEN1KMT2APOLBGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423180-B2 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof IDEMITSU KOSAN CO., LTD. (JP) 2008-09-09 US disclosed
US-20060161016-A1 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof IDEMITSU KOSAN CO., LTD. (JP) 2006-07-20 US disclosed
EP-1602641-A1 BIS(3-AMINO-4-HYDROXYPHENYL)ADAMANTANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF IDEMITSU KOSAN COMPANY LIMITED (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161016-A1 Bis(3-amino-4-hydroxyphenyl)adamantane derivatives and process for production thereof HTR3D, ALKBH3, ALKBH5 GAA 4851/4885MEN1 1616/4885KMT2A 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.